[ad_1]
The Delhi Health Ministry has issued new guidelines related to the production of medicines. It has been said that now the drug manufacturing companies of the country will have to follow the standards of the World Health Organization (WHO) in manufacturing drugs. Drug manufacturers have to take responsibility for the quality of their products. It has to be ensured that there is no risk to the patients with the manufactured medicine.
Pharma companies will have to manufacture medicines only as per licensing criteria. Medicines will have to be released in the market only after complete testing. In the revised guidelines issued by the Ministry of Health, instructions have also been given to withdraw the medicines.
It is clarified that the licensing authority has to be informed before taking back the defective drugs. Along with this, a detailed report will also have to be given as to why the medicine is being withdrawn. It has to be explained what was the defect in the medicine that led to its withdrawal.
So far there was no system to notify the licensing authority before withdrawing any medicine. Pharmaceutical companies have been asked to create a pharmacovigilance system in their company. It will be a monitoring system that will monitor the quality of the company's medicines. Its role will be important if there is any deficiency in the medicine and it needs to be withdrawn.
[ad_2]